AU3132495A - Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids - Google Patents
Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacidsInfo
- Publication number
- AU3132495A AU3132495A AU31324/95A AU3132495A AU3132495A AU 3132495 A AU3132495 A AU 3132495A AU 31324/95 A AU31324/95 A AU 31324/95A AU 3132495 A AU3132495 A AU 3132495A AU 3132495 A AU3132495 A AU 3132495A
- Authority
- AU
- Australia
- Prior art keywords
- antacids
- treatment
- pharmaceutical compositions
- receptor antagonists
- gastrointestinal distress
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27763294A | 1994-07-20 | 1994-07-20 | |
US277632 | 1994-07-20 | ||
PCT/US1995/009004 WO1996002262A2 (en) | 1994-07-20 | 1995-07-18 | Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3132495A true AU3132495A (en) | 1996-02-16 |
Family
ID=23061722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU31324/95A Abandoned AU3132495A (en) | 1994-07-20 | 1995-07-18 | Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU3132495A (en) |
CO (1) | CO4410201A1 (en) |
PE (1) | PE33896A1 (en) |
WO (1) | WO1996002262A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11433024B2 (en) | 2018-04-27 | 2022-09-06 | Johnson & Johnson Consumer Inc. | Liquid oral pharmaceutical dosage form |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2055661A1 (en) * | 1990-12-21 | 1992-06-22 | Manley A. Paulos | Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation |
EP0578732B1 (en) * | 1991-04-04 | 1996-06-19 | The Procter & Gamble Company | Chewable antacid compositions |
ES2077417T3 (en) * | 1991-04-04 | 1995-11-16 | Procter & Gamble | INGERIBLE PHARMACEUTICAL COMPOSITIONS TO TREAT UPPER GASTROINTESTINAL TRACT DISCOMFORTS. |
US5229137A (en) * | 1992-05-06 | 1993-07-20 | Brigham And Women's Hospital, Inc. | Methods and pharmaceutical compositions for treating episodic heartburn |
-
1995
- 1995-07-18 CO CO95031726A patent/CO4410201A1/en unknown
- 1995-07-18 AU AU31324/95A patent/AU3132495A/en not_active Abandoned
- 1995-07-18 WO PCT/US1995/009004 patent/WO1996002262A2/en active Application Filing
- 1995-07-18 PE PE27413595A patent/PE33896A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1996002262A3 (en) | 1997-02-13 |
CO4410201A1 (en) | 1997-01-09 |
PE33896A1 (en) | 1996-09-02 |
WO1996002262A2 (en) | 1996-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6076198A (en) | Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers | |
IL99246A0 (en) | Angiotensin ii receptor antagonists and pharmaceutical compositions containing them | |
IL125735A0 (en) | Pharmaceutical compositions for the treatment of glaucoma | |
NZ299693A (en) | 1,4-dioxino derivatives of indole and quinoline; pharmaceutical compositions | |
HUP9801692A3 (en) | Benzimidazole compounds, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions | |
ZA989150B (en) | Mouth hygienic composition for the treatment of halitosis | |
HUP0001442A3 (en) | Sulfonamide derivatives and pharmaceutical compositions containing them for the treatment of endothelin-mediated disorders | |
IL116998A0 (en) | Novel indoline compounds processes for their preparation and their use for the treatment of CNS disorders | |
HUP0100737A3 (en) | Use of phytosterol for preventing and delaying the onset of alzheimer's disease and phytosterol containing pharmaceutical compositions | |
IL114492A0 (en) | Benzimidazole derivatives their preparation and pharmaceutical compositions containing them | |
AU3642795A (en) | Endothelin receptor antagonists for the treatment of emesis | |
IL118325A0 (en) | Integrin receptor antagonists and pharmaceutical compositions containing them | |
HUP0003851A3 (en) | Pharmaceutical composition for the treatment or prevention of glomerulopathy | |
HUP0600501A3 (en) | Use of cs-866 for producing pharmaceutical composition for the treatment of arteriosclerosis | |
GB2343117B (en) | Benzimidazole pharmaceutical composition and process of preparation | |
IL141081A0 (en) | Use of biogenic estrogen sulfamates for the production of pharmaceutical compositions and pharmaceutical compositions containing biogenic estrogen sulfamates | |
IL113123A (en) | Mono-or bicyclic compounds their preparation and pharmaceutical compositions containing them | |
HUP9904073A3 (en) | Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid | |
IL117623A (en) | Maltitol composition and its preparation | |
HUP9802634A3 (en) | Use of benzimidazoles for the manufacture of pharmaceutical compositions for the treatment of leukemia | |
HUP0004648A3 (en) | 3-substituted tetrahydropyridopyrimidinone derivatives and their use for producing pharmaceutical compositions | |
AU7468096A (en) | Enhanced anti-inflammatory oral composition containing h2 receptor antagonist and antimicrobial oils | |
HUP0002929A3 (en) | 2-acylaminopropanamines as tachykinin receptor antagonists and pharmaceutical compositions containing the same | |
HUP9800631A3 (en) | 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions | |
ZA989238B (en) | Benzimidazole compounds pharmaceutical compositions containing the compounds and their use |